Patrick Dolezal

Stock Analyst at LifeSci Capital

(2.87)

# 1,802

Out of 5,090 analysts

2

Total ratings

100%

Success rate

34.75%

Average return

Main Sectors:

Top Industries:

Biotechnology Drug Manufacturers - Specialty & Generic

Stocks Rated by Patrick Dolezal

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	KOD Kodiak Sciences	Initiates: Outperform	$40	$24.34	+64.34%	1	Oct 23, 2025
	AVDL Avadel Pharmaceuticals	Maintains: Outperform	$17 → $26	$21.34	+21.84%	1	May 2, 2023

Kodiak Sciences

Oct 23, 2025

Initiates: Outperform

Price Target: $40

Current: $24.34

Upside: +64.34%

Avadel Pharmaceuticals

May 2, 2023

Maintains: Outperform

Price Target: $17 → $26

Current: $21.34

Upside: +21.84%